Baillie Gifford Health Innovation Equities Fund DXCM Holdings History
Baillie Gifford Health Innovation Equities Fund's DexCom Inc Holding Summary
As of 2024-09-30, Baillie Gifford Health Innovation Equities Fund held 2,839.00 shares of DexCom Inc(DXCM), totaling $190,330.00. This investment constitutes 2.79% of their stock portfolio, and Baillie Gifford Health Innovation Equities Fund now holds 0% of the outstanding DexCom Inc(DXCM) stock.
The initial trade took place in 2022Q1. And since then Baillie Gifford Health Innovation Equities Fund has made 7 purchases of DXCM, at an average price of $110.49, for a total of 8,466.00 shares. In addition, there have been 2 sales at an average price of $87.71 for 5,627.00 shares. Based on historical transaction data and DXCM's current price of $83.89, Baillie Gifford Health Innovation Equities Fund's estimated gain on his DXCM holdings is $-203,691.87, reflecting a -21.78% gain to date.
Baillie Gifford Health Innovation Equities Fund DXCM ($83.89) Holding Chart
Baillie Gifford Health Innovation Equities Fund DXCM ($83.89) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
